Diagnóstico y tratamiento | 15 MAR 17

Acalasia esofágica

El procedimiento POEM es el adelanto más importante en esta temática
14
17
Autor: Stavropoulos SN, Friedel D, Modayil R, Parkman HP BMJ 2016;354:i2785
INDICE:  1. Página 1 | 2. Referencias Bibliográficas
Referencias Bibliográficas

REFERENCIAS

1 Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am 1989;18:223-55.pmid: 2668168.

2 Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol 2013;108:1238-49, quiz 1250. doi:10.1038/ajg.2013. 196pmid:23877351.

3 Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010;22:e256-61. doi:10. 1111/j.1365-2982.2010.01511.xpmid:20465592.

4 Nenshi R, Takata J, Stegienko S, et al. The cost of achalasia: quantifying the effect of symptomatic disease on patient cost burden, treatment time, and work productivity. Surg Innov 2010;17:291-4. doi:10.1177/1553350610376392pmid:20647236.

5 O’Neill OM, Johnston BT, Coleman HG. Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2013;19:5806-12. doi:10.3748/wjg.v19.i35.5806pmid:24124325.

6 Enestvedt BK, Williams JL, Sonnenberg A. Epidemiology and practice patterns of achalasia in a large multi-centre database. Aliment Pharmacol Ther 2011;33:1209-14. doi:10.1111/ j.1365-2036.2011.04655.xpmid:21480936.

7 Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA 2015;313:1841-52. doi:10.1001/jama.2015.2996pmid:25965233.

8 Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005;100:1404-14. doi:10.1111/j.1572-0241.2005.41775.xpmid: 15929777.

9 de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol 1995;90:1119-24.pmid:7611209.

10 Zárate N, Mearin F, Gil-Vernet JM, Camarasa F, Malagelada JR. Achalasia and Down’s syndrome: coincidental association or something else?Am J Gastroenterol 1999;94:1674-7. doi:10.1111/j.1572-0241.1999.01161.xpmid:10364043.

11 Sarathi V, Shah NS. Triple-A syndrome. Adv Exp Med Biol 2010;685:1-8. doi:10.1007/978-1-4419-6448-9_1pmid:20687490.

12 Tsuboi K, Hoshino M, Srinivasan A, et al. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion 2012;85:236-42. doi:10.1159/000336072pmid:22472689.

13 Shoenut JP, Micflikier AB, Yaffe CS, Den Boer B, Teskey JM. Reflux in untreated achalasia patients. J Clin Gastroenterol 1995;20:6-11. doi:10.1097/00004836-199501000-00004pmid: 7884182.

14 Patti MG, Arcerito M, Tong J, et al. De Pinto M de Bellis M. Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia. J Gastrointest Surg 1997;1:505-10. doi:10.1016/S1091-255X(97)80065-0pmid:9834385.

15 Crookes PF, Corkill S, DeMeester TR. Gastroesophageal reflux in achalasia. When is reflux really reflux?Dig Dis Sci 1997;42:1354-61. doi:10.1023/A:1018873501205pmid:9246028.

16 Novais PA, Lemme EM. 24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy. Aliment Pharmacol Ther 2010;32:1257-65. doi:10.1111/j.1365-2036.2010.04461.xpmid:20955445.

17 Glatz SM, Richardson JD. Esophagectomy for end stage achalasia. J Gastrointest Surg 2007;11:1134-7. doi:10.1007/s11605-007-0226-8pmid:17623258.

18 Madenci AL, Reames BN, Chang AC, Lin J, Orringer MB, Reddy RM. Factors associated with rapid progression to esophagectomy for benign disease. J Am Coll Surg 2013;217:889-95. doi:10.1016/j.jamcollsurg.2013.07.384pmid:24035659.

19 Minami H, Yamaguchi N, Matsushima K, et al. Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis. BMC Gastroenterol 2013; 13:22. doi:10.1186/1471-230X-13-22pmid:23363448.

20 Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 2010; 105:2144-9. doi:10.1038/ajg.2010.263pmid:20588263.

21 Eckardt AJ, Eckardt VF. Editorial: Cancer surveillance in achalasia: better late than never?Am J Gastroenterol 2010;105:2150-2. doi:10.1038/ajg.2010.257pmid:20927062.

22 Brücher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 2001;25:745-9. doi:10.1007/s00268-001-0026-3pmid:11376410.

23 Dunaway PM, Wong RK. Risk and surveillance intervals for squamous cell carcinoma in achalasia. Gastrointest Endosc Clin N Am 2001;11:425-34, ix.pmid:11319071.

24 Leeuwenburgh I, Scholten P, Caljé TJ, et al. Barrett’s esophagus and esophageal adenocarcinoma are common after treatment for achalasia. Dig Dis Sci 2013;58:244-52.doi:10.1007/s10620-012-2157-9pmid:23179142.

25 Hirota WK, Zuckerman MJ, Adler DG, et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80. doi:10.1016/j.gie.2006.02.004pmid:16564854.

26 Parkman HP, Cohen S. Malignancy-induced secondary achalasia. Dysphagia

1993;8:292-6. doi:10.1007/BF01354553pmid:8359052.

27 Tucker HJ, Snape WJ Jr, , Cohen S. Achalasia secondary to carcinoma: manometric and clinical features. Ann Intern Med 1978;89:315-8. doi:10.7326/0003-4819-89-3-315pmid: 686541.

28 Ellingson TL, Kozarek RA, Gelfand MD, Botoman AV, Patterson DJ. Iatrogenic achalasia. A case series. J Clin Gastroenterol 1995;20:96-9. doi:10.1097/00004836-199503000-00004pmid:7769210.

29 Duntemann TJ, Dresner DM. Achalasia-like syndrome presenting after highly selective vagotomy. Dig Dis Sci 1995;40:2081-3. doi:10.1007/BF02208682pmid:7555468.

30 Stylopoulos N, Bunker CJ, Rattner DW. Development of achalasia secondary to laparoscopic Nissen fundoplication. J Gastrointest Surg 2002;6:368-76, discussion 377-8. doi:10.1016/S1091-255X(02)00019-7pmid:12022989.

31 Kia L, Kahrilas PJ. An unusual complication after laparoscopic gastric lap band placement. Gastroenterology 2014;147:e9-10. doi:10.1053/j.gastro.2014.07.043pmid:25450091.

32 Parkman HP, Maurer AH, Caroline DF, Miller DL, Krevsky B, Fisher RS. Optimal evaluation of patients with nonobstructive esophageal dysphagia. Manometry, scintigraphy, or videoesophagography?Dig Dis Sci 1996;41:1355-68. doi:10.1007/BF02088560pmid:8689912.

33 El-Takli I, O’Brien P, Paterson WG. Clinical diagnosis of achalasia: how reliable is the barium x-ray?Can J Gastroenterol 2006;20:335-7. doi:10.1155/2006/193823pmid:16691299.

34 Ott DJ, Richter JE, Chen YM, Wu WC, Gelfand DW, Castell DO. Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol 1987;149:307-11. doi:10.2214/ajr.149.2.307pmid:3496755.

35 Richter JE. High-resolution manometry in diagnosis and treatment of achalasia: help or hype. Curr Gastroenterol Rep 2014;16:420. doi:10.1007/s11894-014-0420-2pmid:25543338.

36 de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol 1997;169:473-9. doi:10.2214/ajr.169.2.9242756pmid:9242756.

37 Pechlivanides G, Chrysos E, Athanasakis E, Tsiaoussis J, Vassilakis JS, Xynos E. Laparoscopic Heller cardiomyotomy and Dor fundoplication for esophageal achalasia: possible factors predicting outcome. Arch Surg 2001;136:1240-3. doi:10.1001/archsurg. 136.11.1240pmid:11695966.

38 Vaezi MF, Baker ME, Richter JE. Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol 1999;94:1802-7. doi: 10.1111/j.1572-0241.1999.01209.xpmid:10406238.

39 Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium  esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol 2013;108:49-55. doi:10.1038/ajg.2012.318pmid:23007004.

40 Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol 2013;108:1238-49, quiz 1250. doi:10.1038/ajg.2013. 196pmid:23877351.

41 Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed?Am J Gastroenterol 2010;105:981-7. doi:10.1038/ajg. 2010.43pmid:20179690.

42 Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008;135:1526-33. doi:10.1053/j.gastro.2008.07.022pmid:18722376.

43 Kahrilas PJ, Bredenoord AJ, Fox M, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015;27:160-74. doi:10.1111/nmo.12477pmid:25469569.

44 Hoogerwerf WA, Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am 2001;11:311-24, vii.pmid:11319064.

45 Bortolotti M, Labò G. Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 1981;80:39-44.pmid:7450409.

46 Penagini , Bartesaghi B, Negri G, Bianchi PA. Effect of loperamide on lower esophageal sphincter pressure in idiopathic achalasia. Scand J Gastroenterol 1994;29:1057-60. doi: 10.3109/00365529409094887pmid:7886391.

47 Marzio L, Grossi L, DeLaurentiis MF, Cennamo L, Lapenna D, Cuccurullo F. Effect of cimetropium bromide on esophageal motility and transit in patients affected by primary achalasia. Dig Dis Sci 1994;39:1389-94. doi:10.1007/BF02088038pmid:8026247.

48 Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 2000;118:253-7. doi:10. 1016/S0016-5085(00)70206-Xpmid:10648452.

49 Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996;110:1410-5. doi: 10.1053/gast.1996.v110.pm8613045pmid:8613045.

50 Annese V, Bassotti G, Coccia G, et al. GISMAD Achalasia Study Group. A multicenter randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gut 2000;46:597-600. doi:10.1136/gut.46.5.597pmid:10764700.

51 Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009;249:45-57. doi:10.1097/SLA.0b013e31818e43abpmid:19106675.

52 Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996;91:1724-30.pmid:8792688.

53 Portale G, Costantini M, Rizzetto C, et al. Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment. J Gastrointest Surg 2005;9:1332-9. doi:10.1016/j.gassur.2005.10.001pmid: 16332491.

54 Orenstein SB, Raigani S, Wu YV, et al. Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy. Surg Endosc 2015;29:1064-70. doi:10.1007/s00464-014-3782-5pmid:25249143.

55 Kadakia SC, Wong RK. Pneumatic balloon dilation for esophageal achalasia. Gastrointest Endosc Clin N Am 2001;11:325-46, vii.pmid:11319065.

56 Katzka DA, Castell DO. Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther 2011;34:832-9.doi:10.1111/j.1365-2036.2011.04816.xpmid:21848630.

57 Zerbib F, Thétiot V, Richy F, Benajah DA, Message L, Lamouliatte H. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006;101:692-7. doi:10.1111/j.1572-0241.2006.00385.xpmid:16635216.

58 Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010;8:30-5. doi:10.1016/j.cgh. 2009.09.020pmid:19782766.

59 Katsinelos P, Kountouras J, Paroutoglou G, et al. Long-term results of pneumatic dilation for achalasia: a 15 years’ experience. World J Gastroenterol 2005;11:5701-5. doi:10.3748/wjg.v11.i36.5587pmid:16237769.

60 Abid S, Champion G, Richter JE, McElvein R, Slaughter RL, Koehler RE. Treatment of achalasia: the best of both worlds. Am J Gastroenterol 1994;89:979-85.pmid:8017394.

61 Wehrmann T, Jacobi V, Jung M, Lembcke B, Caspary WF. Pneumatic dilation in achalasia with a low-compliance balloon: results of a 5-year prospective evaluation. Gastrointest Endosc 1995;42:31-6. doi:10.1016/S0016-5107(95)70239-3pmid:7557173.

62 Guardino JM, Vela MF, Connor JT, Richter JE. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol 2004;38:855-60. doi:10.1097/00004836-200411000-00004pmid:15492600.

63 Dobrucali A, Erzin Y, Tuncer M, Dirican A. Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia. World J Gastroenterol 2004;10:3322-7. doi:10.3748/wjg.v10.i22.3322pmid:15484309.

64 Chan KC, Wong SK, Lee DW, et al. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years’ experience. Endoscopy 2004;36:690-4. doi:10.1055/s-2004-825659pmid:15280973.

65 Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992;103:1732-8. doi:10.1016/0016-5085(92)91428-7pmid:1451966.

66 Yaghoobi M, Mayrand S, Martel M, Roshan-Afshar I, Bijarchi R, Barkun A. Laparoscopic Heller’s myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized, controlled trials. Gastrointest Endosc 2013;78:468-75. doi: 10.1016/j.gie.2013.03.1335pmid:23684149.

67 Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008;2:435-45. doi:10.1586/17474124.2.3.435pmid:19072391.

68 Metman EH, Lagasse JP, d’Alteroche L, Picon L, Scotto B, Barbieux JP. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 1999;94:1179-85. doi:10.1111/j.1572-0241.1999.01062.xpmid:10235189.

69 Heller E. Extramukoese cardinplastik bein chronischen cardiopsasmus mit dilation des oesophagus. Mitt Grenzgeb Med Chir 1914;27:141-5.

70 Oelschlager BK, Chang L, Pellegrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surg 2003;138:490-5, discussion 495-7. oi:10.1001/archsurg. 138.5.490pmid:12742951.

71 Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg 2004;240:405-12, discussion 412-5. doi:10.1097/01.sla.0000136940.32255. 51pmid:15319712.

72 Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006;4:580-7. doi:10.1016/S1542-3565(05)00986-9pmid:16630776.

73 Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg 2005;190:874-8. doi: 10.1016/j.amjsurg.2005.08.012pmid:16307937.

74 Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999;44:231-9. doi:10.1136/gut.44.2. 231pmid:9895383.

75 Ghoshal UC, Chaudhuri S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized ontrolled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus 2001;14:227-31. doi:10.1046/j.1442-2050.2001.00189.xpmid:11869325.

76 Bansal R, Nostrant TT, Scheiman JM, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol 2003;36:209-14. doi:10.1097/00004836-200303000-00005pmid:12590230.

77 Mikaeli J, Farrokhi F, Bishehsari F, Mahdavinia M, Malekzadeh R. Gender effect on clinical features of achalasia: a prospective study. BMC Gastroenterol 2006;6:12. doi:10.1186/1471-230X-6-12pmid:16579859.

78 Bakhshipour A, Rabbani R, Shirani S, Soleimani HA, Mikaeli J. Comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia. Acta Med Iran 2010;48:107-10.pmid:21133003.

79 Leyden JE, Moss AC, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev 2014;12:CD005046.pmid:25485740.

80 Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg 2004; 239:364-70. doi:10.1097/01.sla.0000114217.52941.c5pmid:15075653.

81 Andrews CN, Anvari M, Dobranowski J. Laparoscopic Heller’s myotomy or botulinum toxin injection for management of esophageal achalasia. Patient choice and treatment outcomes. Surg Endosc 1999;13:742-6. doi:10.1007/s004649901090pmid:10430676.

82 Kostic S, Kjellin A, Ruth M, et al. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg 2007;31:470-8. doi:10.1007/s00268-006-0600-9pmid:17308851.

83 Persson J, Johnsson E, Kostic S, Lundell L, Smedh U. Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study. World J Surg 2015;39:713-20. doi:10.1007/s00268-014-2869-4pmid: 25409838.

84 Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 2016;65:732-9. doi:10.1136/gutjnl-2015-310602pmid: 26614104.

85 Csendes A, Braghetto I, Henríquez A, Cortés C. Late results of a prospective randomized study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 1989;30:299-304. doi:10.1136/gut.30.3.299pmid:2651226.

86 Boeckxstaens GE, Annese V, des Varannes SB, et al. European Achalasia Trial Investigators. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med 2011;364:1807-16. doi:10.1056/NEJMoa1010502pmid:21561346.

87 Weber CE, Davis CS, Kramer HJ, Gibbs JT, Robles L, Fisichella PM. Medium and long-term outcomes after pneumatic dilation or laparoscopic Heller myotomy for achalasia: a meta-analysis. Surg Laparosc Endosc Percutan Tech 2012;22:289-96. doi:10.1097/SLE.0b013e31825a2478pmid:22874676.

88 Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009;54:2303-11. doi:10.1007/s10620-008-0637-8pmid:19107596.

89 Schoenberg MB, Marx S, Kersten JF, et al. Laparoscopic Heller myotomy versus endoscopic balloon dilatation for the treatment of achalasia: a network meta-analysis. Ann Surg 2013;258:943-52. doi:10.1097/SLA.0000000000000212pmid:24220600.

90 Ferguson MK, Reeder LB, Olak J. Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg 1996;62:327-30. doi:10.1016/0003-4975(96)00176-2pmid:8694585.

91 Guelrud M, Rossiter A, Souney PF, Sulbaran M. Transcutaneous electrical nerve stimulation decreases lower esophageal sphincter pressure in patients with achalasia. Dig Dis Sci 1991;36:1029-33. doi:10.1007/BF01297442pmid:1864193.

92 Zeng Y, Dai YM, Wan XJ. Clinical remission following endoscopic placement of retrievable, fully covered metal stents in patients with esophageal achalasia. Dis Esophagus 2014;27:103-8. doi:10.1111/dote.12083pmid:23796127.

93 Mikaeli J, Veisari AK, Fazlollahi N, et al. Ethanolamine oleate versus botulinum toxin in the treatment of idiopathic achalasia. Ann Gastroenterol 2015;28:229-35.pmid:25830939.

94 Coppola F, Gaia S, Rolle E, Recchia S. Temporary endoscopic metallic stent for idiopathic esophageal achalasia. Surg Innov 2014;21:11-4.  doi:10.1177/1553350613492024pmid: 23793575.

95 Zhao JG, Li YD, Cheng YS, et al. Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience. Eur Radiol 2009;19:1973-80. doi:10.1007/s00330-009-1373-ypmid:19296113.

96 Cheng YS, Ma F, Li YD, et al. Temporary self-expanding metallic stents for achalasia: a prospective study with a long-term follow-up. World J Gastroenterol 2010;16:5111-7. doi:10.3748/wjg.v16.i40.5111pmid:20976849.

97 Moretó M, Ojembarrena E, Barturen A, Casado I. Treatment of achalasia by injection of sclerosant substances: a long-term report. Dig Dis Sci 2013;58:788-96. doi:10.1007/s10620-012-2476-xpmid:23179151.

98 Sumiyama K, Gostout CJ, Rajan E, Bakken TA, Knipschield MA. Transesophageal mediastinoscopy by submucosal endoscopy with mucosal flap safety valve technique. Gastrointest Endosc 2007;65:679-83. doi:10.1016/j.gie.2006.10.017pmid:17383463.

99 Pasricha PJ, Hawari R, Ahmed I, et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy 2007;39:761-4.doi:10.1055/s-2007-966764pmid:17703382.

100 Ortega JA, Madureri V, Perez L. Endoscopic myotomy in the treatment of achalasia. Gastrointest Endosc 1980;26:8-10. doi:10.1016/S0016-5107(80)73249-2pmid:7358270.

101 Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010;42:265-71. doi:10.1055/s-0029-1244080pmid:20354937.

102 Stavropoulos SN, Harris MD, Hida S, Brathwaite C, Demetriou C, Grendell J. Endoscopic submucosal myotomy for the treatment of achalasia (with video). Gastrointest Endosc 2010;72:1309-11. doi:10.1016/j.gie.2010.04.016pmid:21111876.

103 Stavropoulos SN, Modayil RJ, Friedel D, Savides T. The international per oral endoscopic myotomy survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc 2013;27:3322-38. doi:10.1007/s00464-013-2913-8pmid:23549760.

104 Stavropoulos SN, Desilets DJ, Fuchs KH, et al. NOSCAR POEM White Paper Committee. Per-oral endoscopic myotomy white paper summary. Gastrointest Endosc 2014; 80:1-15. doi:10.1016/j.gie.2014.04.014pmid:24950639.

105 Chandrasekhara V, Desilets D, Falk GW, et al. American Society for Gastrointestinal Endoscopy PIVI Committee. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on peroral endoscopic myotomy. Gastrointest Endosc 2015;81:1087-100.e1. doi:10.1016/j.gie.2014.12.007pmid: 25799295.

106 von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol 2012;107:411-7. doi: 10.1038/ajg.2011.388pmid:22068665.

107 Costamagna G, Marchese M, Familiari P, Tringali A, Inoue H, Perri V. Peroral endoscopic myotomy (POEM) for oesophageal achalasia: preliminary results in humans. Dig Liver Dis 2012;44:827-32. doi:10.1016/j.dld.2012.04.003pmid:22609465.

108 Swanstrom LL, Kurian A, Dunst CM, Sharata A, Bhayani N, Rieder E. Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure. Ann Surg 2012;256:659-67. doi:10.1097/SLA.0b013e31826b5212pmid:22982946.

109 Hungness ES, Teitelbaum EN, Santos BF, et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg 2013;17:228-35. doi:10.1007/s11605-012-2030-3pmid:23054897.

110 Inoue H, Ikeda H, Onimaru M, et al. Clinical results in 300 cases of POEM for esophageal achalasia a single institute registered prospective study. Gastrointest Endosc 2013;77(5S):AB121-2doi:10.1016/j.gie.2013.04.007.

111 Chiu PW, Wu JC, Teoh AY, et al. Peroral endoscopic myotomy for treatment of achalasia: from bench to bedside (with video). Gastrointest Endosc 2013; 77:29-38. doi:10.1016/j. gie.2012.08.018pmid:23043852.

112 Lee BH, Shim KY, Hong SJ, et al. Peroral endoscopic myotomy for treatment of achalasia: initial results of a korean study. Clin Endosc 2013;46:161-7. doi:10.5946/ce.2013.46.2. 161pmid:23614126.

113 Minami H, Isomoto H, Yamaguchi N, et al. Peroral endoscopic myotomy for esophageal achalasia: clinical impact of 28 cases. Dig Endosc 2014;26:43-51. doi:10.1111/den.12086pmid:23581563.

114 Verlaan T, Rohof WO, Bredenoord AJ, Eberl S, Rösch T, Fockens P. Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia. Gastrointest Endosc 2013;78:39-44. doi:10.1016/j.gie.2013.01.006pmid:23453184.

115 Stavropoulos SN, Modayil RJ, Brathwaite CE, et al. Outcomes of a 5-year, large prospective series of per oral endoscopic myotomy (POEM). Emphasis on objective assessment for GERD and luminal patency. Gastrointest Endosc 2015;81(5S):AB118-9doi: 10.1016/j.gie.2015.03.018.

116 Zhou P, Yao L, Zhang YQ, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia: 205 case reports. Gastrointest Endosc 2012;75:AB132-3doi:10.1016/j.gie.2012.04.042.

117 Von Renteln D, Fuchs KH, Fockens P, et al. Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 2013;145:309-11.e1-3. doi:10.1053/j.gastro.2013.04.057pmid:23665071.

118 Charton JP, Schumacher B, Toermer T, et al. Per oral endscopic myotomy (POEM) for achalasia: pilot case series of a Western referral center. Gastrointest Endosc 2013; 77(5S):AB351doi:10.1016/j.gie.2013.03.1163.

119 Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol 2011;8:311-9. doi:10.1038/nrgastro.2011.68pmid:21522116.

120 Kurian AA, Dunst CM, Sharata A, Bhayani NH, Reavis KM, Swanström LL. Peroral endoscopic esophageal myotomy: defining the learning curve. Gastrointest Endosc 2013;77:719-25. doi:10.1016/j.gie.2012.12.006pmid:23394838.

121 Patel KS, Calixte R, Modayil RJ, Friedel D, Brathwaite CE, Stavropoulos SN. The light at the end of the tunnel: a single-operator learning curve analysis for per oral endoscopic myotomy. Gastrointest Endosc 2015;81:1181-7. doi:10.1016/j.gie.2014.10.002pmid:25597422.

122 Sharata AM, Dunst CM, Pescarus R, et al. Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients. J Gastrointest Surg 2015;19:161-70, discussion 170. doi:10.1007/s11605-014-2610-5pmid:25183406.

123 Teitelbaum EN, Soper NJ, Santos BF, et al. Symptomatic and physiologic outcomes one year after peroral esophageal myotomy (POEM) for treatment of achalasia. Surg Endosc 2014;28:3359-65. doi:10.1007/s00464-014-3628-1pmid:24939164.

124 Familiari P, Gigante G, Marchese M, et al. Peroral endoscopic myotomy for esophageal achalasia: outcomes of the first 100 patients with short-term follow-up. Ann Surg 2016;263:82-7. doi:10.1097/SLA.0000000000000992pmid:25361224.

125 Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 2002;50:765-70. doi:10.1136/gut.50.6.765pmid:12010876.

126 Werner YB, Costamagna G, Swanström LL, et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 2016;65:899-906. doi:10.1136/gutjnl-2014-308649pmid:25934759.

127 Inoue H, Sato H, Ikeda H, et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg 2015;221:256-64. doi:10.1016/j.jamcollsurg.2015.03.057pmid:26206634.

128 Modayil R, Stavropoulos SN. A Western perspective on “new NOTES” from POEM to full-thickness resection and beyond. Gastrointest Endosc Clin N Am 2016;26:413-32. doi: 10.1016/j.giec.2015.12.014pmid:27036906.

129 Stavropoulos SN, Modayil R, Braithwaite C, et al. Outcomes of a large prospective series on per oral endoscopic myotomy (POEM) for achalasia: an effective and durable treatment modality than can safely be performed in the endoscopy suite. Gastrointest Endosc 2016;83(5S):AB479-80.

130 Khashab MA, Messallam AA, Onimaru M, et al. International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc 2015;81:1170-7. doi:10.1016/j.gie. 2014.10.011pmid:25634487.

131 Familiari P, Marchese M, Gigante G, et al. Peroral endoscopic myotomy for the treatment of achalasia in children. J Pediatr Gastroenterol Nutr 2013;57:794-7. doi:10.1097/MPG. 0b013e3182a803f7pmid:23941997.

132 Li C, Tan Y, Wang X, Liu D. Peroral endoscopic myotomy for treatment of achalasia in children and adolescents. J Pediatr Surg 2015;50:201-5. doi:10.1016/j.jpedsurg.2014.10. 017pmid:25598123.

133 Chen WF, Li QL, Zhou PH, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc 2015;81:91-100. doi:10.1016/j.gie.2014.06.035pmid:25088923.

134 Caldaro T, Familiari P, Romeo EF, et al. Treatment of esophageal achalasia in children: Today and tomorrow. J Pediatr Surg 2015; 50:726-30. doi:10.1016/j.jpedsurg.2015.02. 047pmid:25783358.

135 Tang X, Gong W, Deng Z, et al. Usefulness of peroral endoscopic myotomy for treating achalasia in children: experience from a single center. Pediatr Surg Int 2015; 31:633-8.doi:10.1007/s00383-015-3717-9pmid:25957132.

136 Nabi Z, Ramchandani M, Reddy DN, et al. Per-oral endoscopic myotomy in children with achalasia cardia. J Neurogastroenterol Motil 2016.  doi: 10.5056/jnm15172pmid:27048658.

137 Petrosyan M, Khalafallah AM, Guzzetta PC, Sandler AD, Darbari A, Kane TD. Surgical management of esophageal achalasia: Evolution of an institutional approach to minimally invasive repair. J Pediatr Surg 2016;S0022-3468(16)30096-3.pmid:27292598.

138 Hu JW, Li QL, Zhou PH, et al. Peroral endoscopic myotomy for advanced achalasia with sigmoid-shaped esophagus: long-term outcomes from a prospective, single-center study. Surg Endosc 2015;29:2841-50. doi:10.1007/s00464-014-4013-9pmid:25492452.

139 Sharata A, Kurian AA, Dunst CM, Bhayani NH, Reavis KM, Swanström LL. Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention. J Gastrointest Surg 2013; 17:1188-92. doi:10.1007/s11605-013-2193-6pmid: 23609138.

140 Vigneswaran Y, Yetasook AK, Zhao JC, Denham W, Linn JG, Ujiki MB. Peroral endoscopic myotomy (POEM): feasible as reoperation following Heller myotomy. J Gastrointest Surg 2014;18:1071-6. doi:10.1007/s11605-014-2496-2pmid:24658904.

141 Onimaru M, Inoue H, Ikeda H, et al. Peroral endoscopic myotomy is a viable option for failed surgical esophagocardiomyotomy instead of redo surgical Heller myotomy: a single center prospective study. J Am Coll Surg 2013;217:598-605. doi:10.1016/j.jamcollsurg. 2013.05.025pmid:23891071.

142 Zhou PH, Li QL, Yao LQ, et al. Peroral endoscopic remyotomy for failed Heller myotomy: a prospective single-center study. Endoscopy 2013;45:161-6. doi:10.1055/s-0032-1326203pmid:23389963.

143 Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71:446-54. doi:10.1016/j.gie.2009.10. 027pmid:20189503.

144 Ren Z, Zhong Y, Zhou P, et al. Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc 2012; 26:3267-72. doi:10.1007/s00464-012-2336-ypmid:22609984.

145 Orenstein SB, Raigani S, Wu YV, et al. Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy. Surg Endosc 2015; 29:1064-70. doi:10.1007/s00464-014-3782-5pmid:25249143.

146 Li QL, Zhou PH, Yao LQ, et al. Early diagnosis and management of delayed bleeding in the submucosal tunnel after peroral endoscopic myotomy for achalasia (with video). Gastrointest Endosc 2013;78:370-4. doi:10.1016/j.gie.2013.04.172pmid:23680177.

147 Li QL, Chen WF, Zhou PH, et al. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg 2013;217:442-51. doi:10.1016/j.jamcollsurg.2013.04.033pmid:23891074.

148 Saleem AM, Hennessey H, von Renteln D, Vassiliou MC. Atrial fibrillation as an unexpected complication after peroral endoscopic myotomy (POEM): a case report. Surg Laparosc Endosc Percutan Tech 2014; 24:e196-9. doi:10.1097/SLE.0000000000000094pmid:25222714.

149 Ujiki MB, Yetasook AK, Zapf M, Linn JG, Carbray JM, Denham W. Peroral endoscopic myotomy: A short-term comparison with the standard laparoscopic approach. Surgery 2013;154:893-7, discussion 897-900. doi:10.1016/j.surg.2013.04.042pmid:24074429.

150 Pannu D, Yang D, Abbitt PL, Draganov PV. Prospective evaluation of CT esophagram findings after peroral endoscopic myotomy. Gastrointest Endosc 2016;84:408-15. doi:10. 1016/j.gie.2016.02.022pmid:26907745.

151 Familiari P, Greco S, Gigante G, et al. Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis. Dig Endosc 2016;28:33-41. doi:10.1111/den.12511pmid:26173511.

152 Csendes A, Braghetto I, Burdiles P, Korn O, Csendes P, Henríquez A. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg 2006;243:196-203. doi:10.1097/01.sla.0000197469.12632.e0pmid:16432352.

153 Kumagai K, Kjellin A, Tsai JA, et al. Toupet versus Dor as a procedure to prevent reflux after cardiomyotomy for achalasia: results of a randomised clinical trial. Int J Surg 2014;12:673-80. doi:10.1016/j.ijsu.2014.05.077pmid:24892729.

154 Khajanchee YS, Kanneganti S, Leatherwood AE, Hansen PD, Swanström LL. Laparoscopic Heller myotomy with Toupet fundoplication: outcomes predictors in 121 consecutive patients. Arch Surg 2005;140:827-33, discussion 833-4. doi:10.1001/archsurg.140.9. 827pmid:16172290.

155 Rawlings A, Soper NJ, Oelschlager B, et al. Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia: results of a multicenter, prospective, randomized-controlled trial. Surg Endosc 2012;26:18-26. doi:10.1007/s00464-011-1822-ypmid:21789646.

156 Simić AP, Radovanović NS, Skrobić OM, Raznatović ZJ, Pesko PM. Significance of limited hiatal dissection in surgery for achalasia. J Gastrointest Surg 2010;14:587-93. doi:10. 1007/s11605-009-1135-9pmid:20033338.

157 Zurita Macías Valadez LC, Pescarus R, Hsieh T, et al. Laparoscopic limited Heller myotomy without anti-reflux procedure does not induce significant long-term gastroesophageal reflux. Surg Endosc 2015;29:1462-8. doi:10.1007/s00464-014-3824-zpmid:25159656.

158 Bhayani NH, Kurian AA, Dunst CM, Sharata AM, Rieder E, Swanstrom LL. A comparative study on comprehensive, objective outcomes of laparoscopic Heller myotomy with per-oral endoscopic myotomy (POEM) for achalasia. Ann Surg 2014; 259:1098-103. doi:10.1097/ SLA.0000000000000268pmid:24169175.

159 Stefanidis D, Richardson W, Farrell TM, Kohn GP, Augenstein V, Fanelli RD. Society of American Gastrointestinal and Endoscopic Surgeons. SAGES guidelines for the surgical treatment of esophageal achalasia. Surg Endosc 2012;26:296-311. doi:10.1007/s00464-011-2017-2pmid:22044977.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí